Changes of Peripheral Blood Lymphocyte Subtypes in Patients with End Stage Cancer Administered Localized Radiotherapy and Bojungikki-Tang

Table 3

The percentages of lymphocyte subsets in the peripheral blood of end stage cancer patients during study period.

Cell type	Surface markers	Time 0		Time 1		Time 2
		BJITE group	Vitamin group	BJITE group	Vitamin group	BJITE group	Vitamin group
Total lymphocytes		12.2±3.8	11.6±2.8	10.4±5.1	10.5±3.3	17.3±8.7	14.9±7.5
T lymphocytes	CD3^+	61.2±11.3	70.2±6.4	62.2±19.7	76.3±10.6	64.8±13.1	71.4±9.5
Helper	CD4^+	33.0±14.1	35.1±7.6	35.9±18.1	39.4±11.9	31.3±7.7	28.8±7.0
Cytotoxic	CD8^+	28.4±13.7	31.1±11.6	23.3±7.0	34.3±17.0	30.6±13.8	40.3±15.3
B lymphocytes	CD19^+	8.8±6.0	10.2±6.1	5.0±2.9	4.0±4.4^∗	7.2±3.8	6.1±5.0^∗
NK cells	CD56^+	25.7±13.9	17.5±7.8	30.1±20.0	16.7±11.1	24.8±15.7	20.7±11.2

^∗𝑃 value < 0.05 was considered statistically significant (Time 0 versus Time 1 and Time 0 versus Time 2 by Wilcoxon’s signed rank sum test).